TGA clearance enables clinical trial initiation for CAMP4 Therapeutics, leading to international expansion efforts.
3 reports, 2 independent
Updated Oct 8
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
TGA clearance enables clinical trial initiation for CAMP4 Therapeutics, leading to international expansion efforts.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Australia granted TGA approval for a new clinical trial.1 source
TGA clearance enables clinical trial initiation for CAMP4 Therapeutics, leading to international expansion efforts.1 source
Keep exploring
The entities involved
-
Therapeutic Goods Administration
regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia
Nothing else this week.
Coverage
Newest first; wire copies grouped- dailypolitical.com
- manilatimes.netCAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder